Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCI-AD, Early Stage Alzheimer's Disease”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Looking for participantsNCT06850597
What this trial is testing

Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

Who this might be right for
MCIMCI-AD, Early Stage Alzheimer's DiseaseAlzheimer's Disease
Medical University of Lodz 30
Not applicableLooking for participantsNCT05081596
What this trial is testing

A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

Who this might be right for
DepressionPainCognitive Impairment
Weill Medical College of Cornell University 100
Testing effectiveness (Phase 2)Study completedNCT02880956
What this trial is testing

Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie 453
Not applicableNot Yet RecruitingNCT07505095
What this trial is testing

Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice

Who this might be right for
Alzheimer Disease (AD)Alzheimer DementiaMCI-AD, Early Stage Alzheimer's Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University 140
Not applicableNot Yet RecruitingNCT06868030
What this trial is testing

Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study

Who this might be right for
Alzheimer's DiseaseMCI-AD, Early Stage Alzheimer's Disease
First Hospital of China Medical University 120
Large-scale testing (Phase 3)Active Not RecruitingNCT03887455
What this trial is testing

Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 1,906
Not applicableLooking for participantsNCT07289061
What this trial is testing

Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function

Who this might be right for
Subjective Cognitive Decline (SCD)Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)
Aristotle University Of Thessaloniki 128
Not applicableActive Not RecruitingNCT05479552
What this trial is testing

A Diagnostic Test for Dementia With Lewy Bodies

Who this might be right for
MCI-AD, Early Stage Alzheimer's DiseaseMCI-DLB, Early Stage Dementia With Lewy Bodies
CND Life Sciences 80
Not applicableActive Not RecruitingNCT02951598
What this trial is testing

Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Eli Lilly and Company 1,400
Testing effectiveness (Phase 2)Study completedNCT04498650
What this trial is testing

Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD

Who this might be right for
Early Alzheimers DiseaseMild Cognitive Impairment Due to AD
Vivoryon Therapeutics N.V. 259
Testing effectiveness (Phase 2)Active Not RecruitingNCT06335173
What this trial is testing

Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 542
Testing effectiveness (Phase 2)Ended earlyNCT03919162
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

Who this might be right for
Alzheimer Disease
Vivoryon Therapeutics N.V. 112
Large-scale testing (Phase 3)Study completedNCT02547818
What this trial is testing

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AZTherapies, Inc. 620
Post-approval studies (Phase 4)Looking for participantsNCT07604896
What this trial is testing

Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs

Who this might be right for
Alzheimer s DiseaseAlzheimer Dementia (AD)MCI-AD, Early Stage Alzheimer's Disease
First Affiliated Hospital of Wenzhou Medical University 200
Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Large-scale testing (Phase 3)Looking for participantsNCT07169578
What this trial is testing

Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Not applicableUnknownNCT03030365
What this trial is testing

Orientation in AD Patients: PET-MR Study

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Assuta Medical Center 30
Early research (Phase 1)Looking for participantsNCT05606341
What this trial is testing

Innate Immunity Stimulation Via TLR9 in Early AD

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Dementia
NYU Langone Health 18
Large-scale testing (Phase 3)Looking for participantsNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT04685590
What this trial is testing

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

Who this might be right for
Alzheimer Disease, Early OnsetMild Cognitive Impairment
Washington University School of Medicine 48